Akineton and Ear barotrauma - a phase IV clinical study of FDA data

Summary:

Ear barotrauma is reported only by a few people who take Akineton.

The phase IV clinical study analyzes which people take Akineton and have Ear barotrauma. It is created by eHealthMe based on reports of 5,814 people who have side effects while taking Akineton from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 10, 2022

5,814 people reported to have side effects when taking Akineton.
Among them, 1 person (0.02%) has Ear barotrauma.

What is Akineton?

Akineton has active ingredients of biperiden hydrochloride. It is often used in parkinson's disease. eHealthMe is studying from 5,851 Akineton users for its effectiveness, alternative drugs and more.

What is Ear barotrauma?

Ear barotrauma (discomfort and possible damage in the ear due to pressure differences between the inside and outside of the eardrum) is found to be associated with 930 drugs and 565 conditions by eHealthMe.

Number of Akineton and Ear barotrauma reports submitted per year:

Gender of people who have Ear barotrauma when taking Akineton *:

female: 100 %
male: 0.0 %

Age of people who have Ear barotrauma when taking Akineton *:

Common drugs people take besides Akineton *:

Common side effects people have besides Ear barotrauma *:

Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 100.00%
Feeling Of Despair: 1 person, 100.00%
Fatigue (feeling of tiredness): 1 person, 100.00%
Eyelid Ptosis (falling of the upper or lower eyelid): 1 person, 100.00%
Eye Pain: 1 person, 100.00%
Drug Ineffective: 1 person, 100.00%
Diplopia (double vision): 1 person, 100.00%
Diabetes Mellitus Inadequate Control: 1 person, 100.00%
Diabetes: 1 person, 100.00%
Depression: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Akineton and have Ear barotrauma?

Check whether Ear barotrauma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Ear barotrauma and when was it recovered:

Ear barotrauma in Akineton

Expand to all the drugs that have ingredients of biperiden hydrochloride:

Ear barotrauma and drugs with ingredients of biperiden hydrochloride

Alternative drugs to, pros and cons of Akineton:

Akineton (5,851 reports)

Common Akineton side effects:

Browse all side effects of Akineton:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Ear barotrauma treatments and more:

Ear barotrauma (1,367 reports)

COVID vaccines that are related to Ear barotrauma:

Common drugs associated with Ear barotrauma:

Fosamax: 298 reports
Zofran: 174 reports
Zometa: 169 reports
Aspirin: 103 reports

All the drugs that are associated with Ear barotrauma:

Ear barotrauma (930 drugs)

Common conditions associated with Ear barotrauma:

Osteoporosis: 264 reports
High blood pressure: 112 reports

All the conditions that are associated with Ear barotrauma:

Ear barotrauma (565 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on biperiden hydrochloride (the active ingredients of Akineton) and Akineton (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.